Cleared Traditional

K884179 - TURBOX FIBRINOGEN

K884179 is the FDA 510(k) clearance for TURBOX FIBRINOGEN by Unipath , Ltd.. It is a Class 2 Hematology device (product code KQJ) cleared through the Traditional 510(k) pathway after a 81-day FDA review.

K884179 · Unipath , Ltd. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1988
Decision
81d
Days
Class 2
Risk

K884179 is an FDA 510(k) clearance for the TURBOX FIBRINOGEN. Classified as System, Fibrinogen Determination (product code KQJ), Class II - Special Controls.

Submitted by Unipath , Ltd. (Bedford Mk41 Oqg, GB). The FDA issued a Cleared decision on December 20, 1988 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7340 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Unipath , Ltd. devices

Submission Details

510(k) Number K884179 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 1988
Decision Date December 20, 1988
Days to Decision 81 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 113d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KQJ System, Fibrinogen Determination
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - KQJ System, Fibrinogen Determination

All 21
Devices cleared under the same product code (KQJ) and FDA review panel - the closest regulatory comparables to K884179.
SPQ TEST SYSTEM II FOR FIB (SERUM PROTEIN QUANTI.)
K900939 · Incstar Corp. · May 1990
COAG-A-MATE - RA4
K900895 · Organon Teknika Corp. · Apr 1990
FIBRINOGEN ASSAY KIT
K896052 · Medical Diagnostic Technologies, Inc. · Nov 1989
FIBRINOGEN ASSAY KIT
K841020 · Helena Laboratories · May 1984
ACA FIBRINOGEN TEST PACK
K812629 · E.I. Dupont DE Nemours & Co., Inc. · Oct 1981
LABCER FIBRINOGEN ASSAY KIT & CALIBR.
K812570 · Sherwood Medical Co. · Oct 1981